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Case report  
 
 
Gastrointestinal Bleeding in COVID-19 Due to Low Personal 
Protective Equipment of a Nurse; a Case Report 
 
 




It is important to diagnose coronavirus disease 2019 (COVID-19) by the clinical 
symptoms, although they are not specific. Clinical symptoms of COVID-19 in 
pediatrics are less severe and milder than in adults, which can be threatening to 
the health staff. In this case study, we report a 23-year old female pediatric nurse 
who developed COVID-19 with the rare symptom of gastrointestinal bleeding 
(GIB). The case of interest was affected by two children who had a positive 
reverse transcription-polymerase chain reaction (RT-PCR). The patient had no 
respiratory symptoms. Despite the use of an N95 mask and face shield, the nurse 
was infected because the gastrointestinal symptoms were predominant. Medical 
staff should pay attention to silent symptoms in pediatrics. Neglecting the use 
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Introduction 
The successive spread of pneumonia related to SARS-
CoV-2 has led to the pandemic of coronavirus disease 
2019 (COVID-19) announcement by the world health 
organization (WHO) on March 11, 2020 (1-3). Due to 
the acute and severe consequences of this viral disease, 
including kidney, respiratory, and other organ 
involvement, China's public, clinical, and scientific 
health associations reacted quickly to identify and treat 
the COVID-19 in the world (3-7). It is important to 
diagnose the clinical symptoms of COVID-19, 
although they are often non-specific. Common 
symptoms are fever, shortness of breath, cough, and 
myalgia or fatigue. Patients may have diarrhea and 
nausea before getting a fever, indicating that the fever 
is predominant but not an absolute sign of infection. A 
small number of patients may experience headaches or 
hemoptysis, and may even be relatively asymptomatic 
(8-10). Children are susceptible to develop COVID-19, 
and there is no significant gender difference. Also, 
clinical symptoms of COVID-19 in pediatrics are less 
severe and milder than in adults (11, 12). We report an 
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affected nurse with gastrointestinal bleeding following 
close contact with the two admissions. 
 
Case Report 
A 23-year-old woman without the underlying disease 
who worked as a pediatric nurse had physical and 
respiratory contact with two pediatric patients with 
gastrointestinal bleeding (GIB) and no respiratory 
symptoms that were hospitalized for endoscopy 
following GIB. Due to suspicious results including 
high C-reaction protein (CRP) and lymphopenia, an 
RT-PCR test has been done for two children from 
nasopharynx and oropharynx, which was positive, and 
the two children were isolated. Two children had low 
volume bloody vomiting over the past three days. 
There was noise reduction in the lower two-thirds of 
the right lung. Reverse transcription-polymerase chain 
reaction (RT-PCR) for COVID-19 with a 
nasopharyngeal swab was positive. Auscultation of the 
lung was accompanied by coarse crackles bilaterally. 
Chest X-ray revealed a consolidation and round 
opacity in the right lung. The two children had not 
apparent symptoms but the results of 
erythrocyte sedimentation rate (ESR) (Mean: 50 
mm/1hr) and C-reactive protein (CRP) (+1) were 
abnormal and suspicious. The affected nurse showed 
gastrointestinal symptoms such as diarrhea, vomiting, 
fever, severe headache, and myalgia four days after 
contact with the two children. So chest x-ray was 
performed immediately, which had no significant 
findings (Figure 1), and in RT-PCR tests from 
nasopharynx and oropharynx, the COVID-19 test was 
positive. Therefore, the patient was quarantined at 
home and treated with azithromycin and 
hydroxychloroquine tablets for 5 days and 
acetaminophen as pro re nata (PRN) to control fever. 
Dry cough and SpO2 of 88% in room air without 
respiratory distress were found two days after 
quarantine. High-resolution computed tomography 
(HRCT) of the chest was requested for the patient. 
There were changes in ground-glass opacity (GGO) in 
the apical segment of the right lower lobe (RLL) 
(Figure 2).  
Due to low SpO2, the patient underwent oxygen 
therapy using a simple face mask (4-5 lit/min) to 
maintain SpO2 above 94% at home. Early detection 
symptoms were pulse rate of 82 beats/minute, 
respiratory rate of 14 breathes/minute, the core 
temperature of 38.50C (axillary), and blood pressure of 
10.5/82 mmHg. Paraclinical tests were as following: 
Platelet per microliter (Plt)=210,000, 
Hemoglobin=10.5 gr/dl, 25 OH vitamin D level= 52 
ng/ml, Aspartate aminotransferase (AST)=23 IU/L, 
Alanine aminotransferase (ALT)=30 IU/L, Alkaline 
phosphatase (ALP)=152 IU/L, CRP=+2 mg/L, 
Erythrocyte sedimentation rate (ESR) =33 mm/hr, 
Blood urea nitrogen (BUN)= 15 mg/dl, Creatinine 
(Cr)=1.1 mg/dl, Lactate dehydrogenase (LDH)= 570 
IU/L , Prothrombin time (PT) = 13 seconds, Partial 
 
Figure 1. Normal chest x-ray of the patient with COVID-
19. 
 
Figure 2. Chest HRCT of the patient with GGO in the 
apical segment of RLL. 
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thromboplastin time (PTT) =32 s, International 
Normalized Ratio (INR)=1.1, Calcium (Ca) =8.8 mg 
/dl, White blood cell per microliter (WBC)=5,200, 
Neutrophils= 75% and Lymphocytes= 17%. The 
patient fully recovered after 5 days and the 
gastrointestinal symptoms and fever were resolved and 





Following the announcement of a pandemic by the 
WHO, more attention has been paid to health care 
organizations in the country so that they can examine 
the disease from different aspects. Further studies in 
different designs are needed to fully know the nature, 
manifestation, and consequences of the COVID-19. 
We report an affected 23-year old female nurse with 
gastrointestinal bleeding following close contact with 
the two children with COVID-19 who had 
gastrointestinal bleeding at admission. Because 
children have mild symptoms, the care providers 
should not be ignored by this fact and should be more 
careful, because few care providers suspect COVID-19 
in pediatrics with gastrointestinal symptoms.  
Therefore, we should not neglect personal 
protective equipment (PPE) especially in close contact 
with children. Given that new drugs can be useful to 
treat or reduce the symptoms such as bromhexine but 
the best strategy in prevention using PPE (13).In a 
study by Xia et al., cough and fever were the most 
common symptoms in 13 children with COVID-19; six 
patients had unilateral pulmonary lesions; ten patients 
had bilateral pulmonary lesions, and also four patients 
were normal on CT. The majority of patients had 
ground‐glass opacities (n=12) and consolidation 
(n=10) (13).  
The results of Xia et al. were consistent with our 
report regarding the symptoms and radiological 
findings of the two children affecting the nurse with 
COVID-19. However, the symptoms of the affected 
nurse were similar to the two children, in which the 
nurse had GIB because of the main display of COVID-
19 in the two children with GIB. 
Another study revealed that about 90% of 
COVID-19 children were asymptomatic, and in some 
cases were mild or moderate (14); the latter findings 
ring a bell to care providers to be alert about the 
possibility of COVID-19 in pediatrics without 
apparent symptoms. It should be stated that children of 
all ages are prone to develop COVID-19, and there is 
no significant difference between the male and female 
gender. Even the slightest symptoms and signs of 
COVID-19 in children should lead us to the diagnosis 
of COVID-19 because discretion is the key to 
maintaining good health among all people, especially 
in care providers. Transmission of the COVID-19 in 
the populous area should be considered serious and 
paid more attention in which populous areas such as 
closed places or metropolis (15).  
As mentioned, the two children with COVID-19 
as a carrier had hematemesis accompanied by the noise 
reduction in the lower two-thirds of the right lung. Mild 
symptoms of children with COVID-19 must be paid 
attention to by care providers. Hence, there is a mild 
symptom, the use of radiologic imaging and molecular 
tests are useful to detect COVID-19. The children can 
manifest COVID-19 atypically and it is dangerous to 




Due to the atypical and mild clinical symptoms of 
COVID19 in children such as our reported case, it is 
necessary to educate the medical staff about the 
importance of gastrointestinal symptoms in addition to 
the respiratory symptoms of pediatric patients as 
possible symptoms of COVD19. Neglecting the use of 
personal protective equipment in dealing with pediatric 
patients can be hazardous. Medical staff should pay 
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